Intravenous immunoglobulin (IVIG) has been successfully used to treat
autoimmune diseases, We report dramatic, rapid and sustained responses
to its use in two cases of vasculitis: a patient with primary angiiti
s of the central nervous system; and a patient with hepatitis-B-antige
n-related polyarteritis nodosa, who failed treatment with corticostero
ids. Improvement in gait and a marked decrease in serum creatinine, re
spectively, were observed within 24 h of the first dose of IVIG, Both
patients remained stable for several months, We conclude that IVIG sho
uld be considered in patients with vasculitis who fail corticosteroids
, or when a rapid response is required.